Research & Development

New Framework Targets Overlooked MET Fusions
Research & Development New Framework Targets Overlooked MET Fusions

A pivotal study in precision oncology is poised to reshape how clinicians approach cancers driven by specific genetic alterations, offering a detailed roadmap for identifying and treating mutations that have long been underrecognized. Led by Dr. Wei Yang and his team, the research introduces a

Dual-Action Cancer Vaccine Shows Promise in First Trial
Research & Development Dual-Action Cancer Vaccine Shows Promise in First Trial

A groundbreaking personalized cancer therapy that essentially teaches a patient's own immune system how to recognize and destroy their specific tumor has delivered remarkable results in its initial human trial, signaling a potential new era in the fight against advanced solid tumors. This

Pre-Surgery Immunotherapy Cures Rare Melanoma
Research & Development Pre-Surgery Immunotherapy Cures Rare Melanoma

A recent clinical trial has successfully demonstrated that treating a rare and aggressive skin cancer with immunotherapy before surgery can completely eliminate tumors in the majority of patients, heralding a profound shift in how this formidable disease is managed. The groundbreaking research,

Does Your Diet's Melatonin Fight Obesity and Depression?
Research & Development Does Your Diet's Melatonin Fight Obesity and Depression?

The intricate connection between what we eat and how we feel extends far beyond calories and vitamins, reaching into the complex world of hormones naturally present in our daily meals. While widely recognized as the body's sleep regulator, melatonin is emerging from the shadows of the circadian

Statins May Overcome Cancer Immunotherapy Resistance
Research & Development Statins May Overcome Cancer Immunotherapy Resistance

We're joined today by Ivan Kairatov, a biopharma expert whose work at the intersection of technology and R&D provides a unique lens on the future of oncology. While immune checkpoint inhibitors have revolutionized cancer treatment, the stark reality is that most patients don't respond, largely due

Is Cancer Immunotherapy More Than Just T Cells?
Research & Development Is Cancer Immunotherapy More Than Just T Cells?

The remarkable success of cancer immunotherapy has long been attributed almost exclusively to the power of T cells, yet a groundbreaking investigation now reveals a previously hidden ally crucial to winning the fight against tumors. This research summary examines a pivotal study that challenges the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later